New News information at Pharmaceutical Technology New and updated information from News listed on pharmaceutical-technology.com http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ New News information at Pharmaceutical Technology http://www.pharmaceutical-technology.com/content/images/logo_big.gif UK scientists hail brain disease breakthrough http://www.pharmaceutical-technology.com/news/newsuk-scientists-hail-brain-disease-breakthrough http://www.pharmaceutical-technology.com/news/newsuk-scientists-hail-brain-disease-breakthrough Scientists in the UK have mapped a pathway that generates “aberrant” forms of proteins at the root of degenerative diseases such as Alzheimer’s and Parkinson’s. Mon, 20 May 2013 23:00:00 GMT Ranbaxy Laboratories gets tentative approval for HIV combination therapy http://www.pharmaceutical-technology.com/news/newsranbaxy-laboratories-gets-tentative-approval-for-hiv-combination-therapy http://www.pharmaceutical-technology.com/news/newsranbaxy-laboratories-gets-tentative-approval-for-hiv-combination-therapy The US Food and Drug Administration has granted tentative approval for a fixed dose formulation of two generic drugs for use in combination with antiretrovirals. Mon, 20 May 2013 23:00:00 GMT Bayer acquires herbal medicines manufacturer http://www.pharmaceutical-technology.com/news/newsbayer-acquires-herbal-medicines-manufacturer http://www.pharmaceutical-technology.com/news/newsbayer-acquires-herbal-medicines-manufacturer Bayer Pharmaceuticals has struck a deal to acquire Germany’s Steigerwald Arzneimittelwerk, a privately held company specialising in herbal medicines. Sun, 19 May 2013 23:00:00 GMT Elan strikes two more drug deals to fend off Royalty Pharma bid http://www.pharmaceutical-technology.com/news/newselan-strikes-two-more-drug-deals-to-fend-off-royalty-pharma-bid http://www.pharmaceutical-technology.com/news/newselan-strikes-two-more-drug-deals-to-fend-off-royalty-pharma-bid Irish pharmaceutical company Elan has agreed to buy two private drug companies and plans to buy back more shares as it looks to fend off a takeover bid from US investment firm Royalty Pharma. Sun, 19 May 2013 23:00:00 GMT FDA approves radiation prostate cancer drug http://www.pharmaceutical-technology.com/news/newsfda-approves-radiation-prostate-cancer-drug http://www.pharmaceutical-technology.com/news/newsfda-approves-radiation-prostate-cancer-drug The US Food and Drug Administration has approved a new drug for the treatment of an advanced type of prostate cancer that spreads to the bones. Thu, 16 May 2013 23:00:00 GMT UK firm halts sale of convulsion drug to Arkansas over death row use http://www.pharmaceutical-technology.com/news/newsuk-firm-halts-sale-of-convulsion-drug-to-arkansas-over-death-row-use http://www.pharmaceutical-technology.com/news/newsuk-firm-halts-sale-of-convulsion-drug-to-arkansas-over-death-row-use UK-based pharmaceutical company Hikma has stopped supplying convulsion drug phenobarbital to Arkansas in the US to prevent it being used in state executions. Thu, 16 May 2013 23:00:00 GMT US human cloning breakthrough turns skin cells into embryos http://www.pharmaceutical-technology.com/news/newsus-human-cloning-breakthrough-turns-skin-cells-into-embryos http://www.pharmaceutical-technology.com/news/newsus-human-cloning-breakthrough-turns-skin-cells-into-embryos For the first time ever, scientists in the US have turned human skin cells into early-stage embryos, which were then used to create specialised tissue cells for transplant operations. Wed, 15 May 2013 23:00:00 GMT Roche releases positive results for first-of-its-kind leukaemia drug http://www.pharmaceutical-technology.com/news/newsroche-releases-positive-results-for-first-of-its-kind-leukaemia-drug http://www.pharmaceutical-technology.com/news/newsroche-releases-positive-results-for-first-of-its-kind-leukaemia-drug A Phase III study into the effectiveness of a first-of-its-kind targeted cancer antibody drug developed by Roche for patients with chronic lymphocytic leukaemia (CLL) and co-existing medical conditions has yielded positive results. Wed, 15 May 2013 23:00:00 GMT Low-cost Rotavirus vaccine revealed by scientists in India http://www.pharmaceutical-technology.com/news/newslow-cost-rotavirus-vaccine-revealed-by-scientists-in-india http://www.pharmaceutical-technology.com/news/newslow-cost-rotavirus-vaccine-revealed-by-scientists-in-india A new vaccine to prevent Rotavirus, which kills around half a million children a year, has been unveiled by scientists in India. Tue, 14 May 2013 23:00:00 GMT Human Rights Watch welcomes Ukraine’s palliative care breakthrough http://www.pharmaceutical-technology.com/news/newshuman-rights-watch-welcomes-ukraines-palliative-care-breakthrough http://www.pharmaceutical-technology.com/news/newshuman-rights-watch-welcomes-ukraines-palliative-care-breakthrough The Human Rights Watch has welcomed Ukraine's approval of new regulations that will allow greater access to strong painkillers, such as morphine. Tue, 14 May 2013 23:00:00 GMT Eli Lilly Phase III lymphoma study fails to meet primary endpoint http://www.pharmaceutical-technology.com/news/newseli-lilly-phase-iii-lymphoma-study-fails-to-meet-primary-endpoint http://www.pharmaceutical-technology.com/news/newseli-lilly-phase-iii-lymphoma-study-fails-to-meet-primary-endpoint Eli Lilly has announced that its Phase III clinical trial of enzastaurin for the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL) has failed, after results did not meet the trial's primary endpoint. Mon, 13 May 2013 23:00:00 GMT Ranbaxy pays record fine in adulterated drugs case http://www.pharmaceutical-technology.com/news/newsranbaxy-pays-record-fine-in-adulterated-drugs-case http://www.pharmaceutical-technology.com/news/newsranbaxy-pays-record-fine-in-adulterated-drugs-case Indian drug maker Ranbaxy Laboratories has agreed to pay a record fine to settle a criminal and civil lawsuit related to drug safety. Mon, 13 May 2013 23:00:00 GMT Deadly coronavirus may be able to spread from person to person, say WHO http://www.pharmaceutical-technology.com/news/newsdeadly-coronavirus-may-be-able-to-spread-from-person-to-person-say-who http://www.pharmaceutical-technology.com/news/newsdeadly-coronavirus-may-be-able-to-spread-from-person-to-person-say-who Current and previous cases suggest that the deadly novel coronavirus, which has killed 18 people, can be spread from person to person, the World Health Organisation (WHO) has said in a statement. Sun, 12 May 2013 23:00:00 GMT GSK wins approval for COPD drug http://www.pharmaceutical-technology.com/news/newsgsk-wins-approval-for-copd-drug http://www.pharmaceutical-technology.com/news/newsgsk-wins-approval-for-copd-drug GlaxoSmithKline's Breo Ellipta for the treatment of chronic obstructive pulmonary disease (COPD) has been approved by the US Food and Drug Administration. Sun, 12 May 2013 23:00:00 GMT Bacteria makes mosquitoes resistant to malaria: study http://www.pharmaceutical-technology.com/news/newsbacteria-makes-mosquitoes-resistant-to-malaria-study http://www.pharmaceutical-technology.com/news/newsbacteria-makes-mosquitoes-resistant-to-malaria-study Scientists in the US have discovered a strain of bacteria that could prevent the transmission of malaria via mosquitoes to humans. Thu, 09 May 2013 23:00:00 GMT GSK and Save the Children partner to save one million lives http://www.pharmaceutical-technology.com/news/newsgsk-and-save-the-children-partner-to-save-one-million-lives http://www.pharmaceutical-technology.com/news/newsgsk-and-save-the-children-partner-to-save-one-million-lives GlaxoSmithKline (GSK) and charity Save the Children have joined forces to run two flagship programmes aimed at saving the lives of some of the world's poorest children. Thu, 09 May 2013 23:00:00 GMT Shire signs rare disease discovery deal with Nimbus http://www.pharmaceutical-technology.com/news/newsshire-signs-rare-disease-discovery-deal-with-nimbus http://www.pharmaceutical-technology.com/news/newsshire-signs-rare-disease-discovery-deal-with-nimbus Shire, the UK's third largest pharmaceutical firm, has teamed up with US-based Nimbus Discovery to develop small molecule treatments for rare genetic diseases. Wed, 08 May 2013 23:00:00 GMT Spider venom vaccine a future possibility due to new research http://www.pharmaceutical-technology.com/news/newsspider-venom-vaccine-a-future-possibility-due-to-new-research http://www.pharmaceutical-technology.com/news/newsspider-venom-vaccine-a-future-possibility-due-to-new-research Brazilian scientists have created a synthetic protein that could one day lead to a vaccination against poisonous spider venom. Wed, 08 May 2013 23:00:00 GMT Scottish cancer drug fund rejected by experts http://www.pharmaceutical-technology.com/news/newsscottish-cancer-drug-fund-rejected-by-experts http://www.pharmaceutical-technology.com/news/newsscottish-cancer-drug-fund-rejected-by-experts Cancer should not be singled out for a special drugs fund in Scotland, say experts who carried out a review into Scotland's system for approving drugs. Tue, 07 May 2013 23:00:00 GMT Pfizer to sell Viagra online to combat sales of fake pills http://www.pharmaceutical-technology.com/news/newspfizer-to-cell-viagra-online-to-combat-sales-of-fake-pills http://www.pharmaceutical-technology.com/news/newspfizer-to-cell-viagra-online-to-combat-sales-of-fake-pills Pfizer has launched a website to sell Viagra, the world's leading erectile dysfunction drug, in a bid to stop the escalating trade of fake pills. Tue, 07 May 2013 23:00:00 GMT